Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
146 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Cellceutix Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Cellceutix Corporation - Product Pipeline Review - 2014', provides an overview of the Cellceutix Corporation's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Cellceutix Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Cellceutix Corporation including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Cellceutix Corporation's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Cellceutix Corporation's pipeline products Reasons to buy - Evaluate Cellceutix Corporation's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Cellceutix Corporation in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Cellceutix Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Cellceutix Corporation and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cellceutix Corporation - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Cellceutix Corporation and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Cellceutix Corporation Snapshot 6 Cellceutix Corporation Overview 6 Key Information 6 Key Facts 6 Cellceutix Corporation - Research and Development Overview 7 Key Therapeutic Areas 7 Cellceutix Corporation - Pipeline Review 14 Pipeline Products by Stage of Development 14 Pipeline Products - Monotherapy 15 Cellceutix Corporation - Pipeline Products Glance 16 Cellceutix Corporation - Clinical Stage Pipeline Products 16 Cellceutix Corporation - Early Stage Pipeline Products 18 Cellceutix Corporation - Drug Profiles 23 brilacidin 23 Kevetrin 25 KM-133 28 CTIX-1278 30 KM-277 31 KM-278 32 KM-3174 33 KM-362 34 KM-391 35 KM-732 37 PMX-0196 38 PMX-0231 39 PMX-0243 41 PMX-10072 43 PMX-10098 44 PMX-1207 45 PMX-1241 46 PMX-1278 47 PMX-1405 48 PMX-1408 49 PMX-1502 50 PMX-20005 51 PMX-207 52 PMX-225 53 PMX-30016 54 PMX-496 55 PMX-504 56 PMX-519 57 PMX-611 58 PMX-647 59 PMX-70004 60 PMX-70008 61 PMX-835 62 PMX-100 63 PMX-10070 64 PMX-1014 65 PMX-1045 66 PMX-1056 67 PMX-1057 68 PMX-1090 69 PMX-1091 70 PMX-1094 71 PMX-1099 72 PMX-1102 73 PMX-1142 74 PMX-1363 75 PMX-1424 76 PMX-1442 77 PMX-1445 78 PMX-1467 79 PMX-1488 80 PMX-1533 81 PMX-1547 82 PMX-1555 83 PMX-1560 84 PMX-1570 85 PMX-1572 86 PMX-1573 87 PMX-1576 88 PMX-1591 89 PMX-1625 90 PMX-183 91 PMX-223 92 PMX-229 93 PMX-247 94 PMX-255 95 PMX-30024 96 PMX-30053 97 PMX-520 98 PMX-633 99 PMX-668 100 PMX-693 101 PMX-728 102 PMX-741 103 PMX-843 104 PMX-868 105 Cellceutix Corporation - Pipeline Analysis 106 Cellceutix Corporation - Pipeline Products by Target 106 Cellceutix Corporation - Pipeline Products by Route of Administration 107 Cellceutix Corporation - Pipeline Products by Molecule Type 108 Cellceutix Corporation - Pipeline Products by Mechanism of Action 109 Cellceutix Corporation - Recent Pipeline Updates 110 Cellceutix Corporation - Dormant Projects 138 Cellceutix Corporation - Locations And Subsidiaries 139 Head Office 139 Appendix 140 Methodology 140 Coverage 140 Secondary Research 140 Primary Research 140 Expert Panel Validation 140 Contact Us 141 Disclaimer 141
List of Tables Cellceutix Corporation, Key Information 11 Cellceutix Corporation, Key Facts 11 Cellceutix Corporation - Pipeline by Indication, 2014 14 Cellceutix Corporation - Pipeline by Stage of Development, 2014 19 Cellceutix Corporation - Monotherapy Products in Pipeline, 2014 20 Cellceutix Corporation - Phase II, 2014 21 Cellceutix Corporation - Phase I, 2014 22 Cellceutix Corporation - Preclinical, 2014 23 Cellceutix Corporation - Discovery, 2014 25 Cellceutix Corporation - Pipeline by Target, 2014 111 Cellceutix Corporation - Pipeline by Route of Administration, 2014 112 Cellceutix Corporation - Pipeline by Molecule Type, 2014 113 Cellceutix Corporation - Pipeline Products by Mechanism of Action, 2014 114 Cellceutix Corporation - Recent Pipeline Updates, 2014 115 Cellceutix Corporation - Dormant Developmental Projects,2014 143
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.